Why would Trump take remdesivir?
Asked by: Mrs. Robyn Gaylord Sr. | Last update: July 1, 2026Score: 5/5 (35 votes)
President Trump took remdesivir in October 2020 as part of a multi-drug regimen to treat COVID-19 after he was hospitalized at Walter Reed National Military Medical Center. It was prescribed to combat the virus, as studies indicated the antiviral drug helped patients recover faster by interfering with the replication of the coronavirus.
Did Trump take remdesivir when he had COVID?
Trump Is Taking Remdesivir. Here's How It Works To Control The Coronavirus. President Trump is on day two of a planned 5-day course of remdesivir. The medication, approved for treating COVID-19, works by making it harder for the coronavirus to replicate within the body.
What is the purpose of remdesivir?
Remdesivir (brand name Veklury) is an antiviral medication approved for treating COVID-19 in adults and children (28 days of age and older, weighing at least 3 kg). It is used for hospitalized patients and non-hospitalized individuals with mild-to-moderate COVID-19 at high risk of disease progression.
What is the issue with remdesivir?
Remdesivir (Veklury) is an antiviral used for COVID-19 with well-documented side effects, including potential liver enzyme elevation, kidney injury, and infusion reactions. While generally well-tolerated, serious adverse events like hypotension, respiratory failure, and organ failure have been reported. Efficacy, particularly in reducing long-term symptoms or mortality, has shown mixed results in various studies.
Who recommends against the use of remdesivir?
WHO Guideline Development Group advises against use of remdesivir for covid-19 | BMJ.
President Trump is taking Remdesivir, but what exactly is Remdesivir?
How toxic is remdesivir?
On a cellular level, remdesivir has been demonstrated to be toxic to human hepatocytes, and the FDA has cautioned about the incidence of elevated liver enzymes in patients treated with remdesivir, indicating potential drug-induced liver injury.
Does remdesivir cause organ failure?
We found 2,922 reports with remdesivir registered in FAERS for COVID-19. Among these, 493 renal and urinary adverse effects (16.9%) were reported. The most frequent events were acute kidney injury (338; 11.6%), renal impairment (86; 2.9%), and renal failure (53; 1.8%).
What is the mortality rate for remdesivir?
Results: A total of 1,895 patients from 9 studies were included in this qualitative synthesis. In patients treated with Remdesivir, the mean recovery time was 15.84 days (95% CI 11.68–20, SE 2.12; I2 = 97.24) and the pooled mortality rate was 11.3% (95% CI 7.9–16%; I2 = 74.85).
What are the major side effects of remdesivir?
Side Effects
- Back pain.
- chest tightness.
- chills.
- cough.
- dark-colored urine.
- difficulty swallowing.
- fast heartbeat.
- fever.
Which is better, Paxlovid or remdesivir?
The findings of the present investigation revealed a lower number of patients from the remdesivir group being discharged than the Paxlovid group. The EPIC-HR trial showed that Paxlovid lowers the risk of hospital admission among patients with mild to moderate COVID-19.
What does remdesivir do to the lungs?
Remdesivir Inhibits TGF-β1-Induced Activation of Smad and Non-smad Signaling Pathways in Lung Fibroblasts. The TGF-β1 signaling pathway is critical in regulating the proliferation and activation of fibroblasts in pulmonary fibrosis (Aschner and Downey, 2016).
What was remdesivir originally made for?
Remdesivir was originally developed by Gilead Sciences in 2009 to treat Hepatitis C and respiratory syncytial virus (RSV). It was later repurposed to treat Ebola virus disease, where it was tested in clinical trials during the 2013–2016 West African outbreak, before being ultimately used for COVID-19.
How often is remdesivir given?
Non-hospitalized patients at high risk for disease progression may be given a 3-day course of remdesivir (200 mg IV on day 1, followed by 100 mg IV on days 2 and 3).
Who funded remdesivir?
Multiple federal agencies support biomedical research and development, which can directly or indirectly contribute to the development of new drugs like remdesivir. These federal agencies include NIH—the largest public funder of biomedical research in the world—as well as CDC and DOD.
Did Trump use Paxlovid?
What kind of regimen was the president taking? Paxlovid comes in pill form, in contrast to remdesivir, the intravenous antiviral drug that former president Trump was given when he contracted COVID-19 and was cared for at Walter Reed National Military Medical Center.
What is Trump's net worth?
Donald Trump's net worth is approximately $6.5 billion. This figure fluctuates with the market and is derived from his real-time wealth tracking on the Forbes 400.
What is the controversy with remdesivir?
Remdesivir (Veklury) is a Gilead Sciences antiviral drug approved by the FDA to treat COVID-19 in hospitalized patients, yet it has faced controversy due to conflicting evidence on its mortality benefits, high costs, and potential side effects, including kidney and liver issues. While early trials suggested shorter recovery times, major studies found little to no impact on mortality.
Does the COVID vaccine damage the kidneys?
In addition, cases of acute kidney injury (AKI) have been reported after COVID-19 vaccination 17. Whether COVID-19 vaccination is associated with renal dysfunction remains uncertain. Given the relatively small sample sizes of previous studies, investigation of this association in a higher number of patients is needed.
What destroys the kidneys the most?
Uncontrolled diabetes and high blood pressure (hypertension) are the top two causes of kidney destruction, responsible for roughly two-thirds of all cases. These conditions damage the blood vessels and nephrons in the kidney over time, leading to chronic kidney disease (CKD) or kidney failure.
How many died from remdesivir?
Clinical trials and studies have not found that Remdesivir increases deaths in patients; rather, it is associated with a 17–25% reduction in the risk of in-hospital death compared to non-use. Studies found that roughly 5.4%–14.5% of patients treated with remdesivir died, often less than control groups.
What are the long term side effects of Pfizer Covid vaccine?
Long-term side effects from the Pfizer-BioNTech COVID-19 vaccine are rare, but reported potential issues include myocarditis/pericarditis (heart inflammation), persistent fatigue, headaches, and menstrual changes. Most vaccine side effects are mild and occur within 1–3 days, but some symptoms can last for several weeks or months in rare cases.
Are there long-term effects of remdesivir?
Remdesivir (Veklury) is generally considered to have no significant, widespread long-term side effects 300 days post-hospitalization, with studies showing no difference in long-term symptom persistence compared to untreated patients. While rare acute risks like kidney injury and liver enzyme elevation exist, long-term monitoring has not indicated chronic toxicity.
What is the success rate of remdesivir for COVID patients?
The U.S. Food and Drug Administration even broadened the scope of the existing EUA for Remdesivir to include treatment of all hospitalized adult patients irrespective of their severity. We observed a 78% success rate with Remdesivir, 44% with CP and only 13% with the combination of three [Remdesivir, CP, and TCZ].
How much does remdesivir injection cost?
Price. Remdesivir costs approximately $3,120 per treatment for U.S. patients with private insurance. Uninsured individuals will be covered under provisions of the Coronavirus Aid, Relief, and Economic Security Act.